Get emergency contraception for as low as $0 with insurance →
Get emergency contraception for as low as $0 with insurance →
GLP-1 and GIP medications can significantly support weight loss and help manage symptoms of type 2 diabetes by mimicking hormones your body naturally uses to regulate blood sugar and appetite.
GLP-1 medications are often preferred over traditional stimulant-based weight-loss drugs because they are non-stimulant, promote steady appetite regulation, and can also improve blood sugar control. Your provider will determine the most appropriate option based on your individual health profile.
What’s Included
Why ReMDi Weight Optimization Is Different
Most programs focus only on the scale. ReMDi focuses on metabolism, hormones, longevity, and body composition — creating change that lasts.
We personalize every plan through:
Advanced metabolic labs
Prescription GLP-1/GIP medications (when appropriate)
Peptide and protein optimization
Longevity-focused supplementation
Continuous clinical guidance
A whole-body approach designed to protect muscle, metabolism, and long-term health
Because weight loss shouldn’t just change your weight — it should improve your life span and health span.
Clear, Simple Pricing
For most GLP-1/GIP medications, our pricing is fully transparent from the start.
For Zepbound® or Wegovy®, a consultation is required before prescribing and includes ongoing support once you join our monthly membership.
If you do not qualify for treatment, your $45 consultation fee will be refunded.
Pricing Notes:
• Zepbound® is purchased separately through LillyDirect®.
• Wegovy® is purchased through NovoCare.
• You may choose to send your prescription to your preferred pharmacy, where savings cards or insurance may help reduce costs.
| Medication | Active Ingredient | FDA-Approved For | Average Weight Loss | How It’s Taken | Dosing Options |
|---|---|---|---|---|---|
| Wegovy® | Semaglutide | Chronic weight management (BMI ≥30, or ≥27 with a weight-related condition) | ~15% | Weekly auto-injector | 0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg |
| Ozempic® | Semaglutide | Type 2 diabetes (often prescribed off-label for weight loss) | ~12% | Weekly auto-injector | 0.25 mg → 0.5 mg → 1.0 mg → 2.0 mg |
| Mounjaro® | Tirzepatide | Type 2 diabetes (also used off-label for weight loss) | ~20–22% | Weekly auto-injector | 2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg |
| Zepbound® | Tirzepatide | Chronic weight management (BMI ≥30, or ≥27 with a weight-related condition) | ~21–22% | Weekly auto-injector | 2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg |
Sign up for emails to know the latest on ReMDi offerings, hand-picked women’s health news, and more.
